Deepak Atri

Investing Profile

Sweet spot: $38.5M Range: $2M–$75M Fund: $668M

Foresite Capital thesis

"Foresite Capital has been a visionary partner." Serge Saxonov, CEO & Co-Founder 10x Genomics (See Disclosures) “Foresite Capital’s deep industry knowledge and in-house expertise has helped fuel our mission to outsmart cancer resistance.” Tim Clackson Theseus Pharmaceuticals (See Disclosures) "The Foresite team contributed meaningful scientific and strategic insights that supported our path from concept to acquisition in just over two years. Their partnership allowed our small team to move more quickly and decisively than we could have alone." Chris LeMasters XinThera (See Disclosures) "The Fo

Sector and stage focus

  • Seed: Drug Delivery, Pharmaceuticals, Medical Devices, Diagnostics, BioTech, Digital Health, Therapeutics, Health IT
  • Series B: Drug Delivery, Pharmaceuticals, Medical Devices, BioTech, Diagnostics, Digital Health, Therapeutics, Health IT
  • Series A: Therapeutics, Pharmaceuticals, BioTech, Medical Devices, Health IT, Diagnostics, Drug Delivery, Digital Health

Is Deepak Atri a fit for your round?

Upload your pitch deck and see whether Deepak Atri appears in your top 20 matches.

Find investors for your deck